시장보고서
상품코드
1479730

세계의 녹내장 치료제 시장(2024년) : 시장 분석(2023-2029년)

2024 Glaucoma Pharmaceuticals Market Report: Global Analysis for 2023 to 2029

발행일: | 리서치사: Market Scope, LLC | 페이지 정보: 영문 | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이 보고서는 세계 녹내장 치료제 시장을 조사하고 브랜드 프로스타글란딘, 제네릭 프로스타글란딘, 베타 차단제, 탄산탈수효소 억제제, 알파 작용제, 고정 콤보제, NO 공여성 화합물, Rho 키나아제 억제제에 대한 2029년까지의 예측을 제시합니다. 또한, 현재 개발 중인 30개 이상의 의약품 후보물질과 파이프라인 제품에 대해서도 폭넓게 다루고 있습니다. 또한, 26개 녹내장 제약사들을 프로파일링하여 제품, 전략적 시장 포지션, 배경, 전망 등을 제공합니다.

목차

  • 녹내장 종류와 위험인자
  • 질환 진단과 치료
  • 안과의나 검안사를 포함한 녹내장 의료 제공자의 세계 관점
  • 세계의 질환 유병률 예측(5년간)
  • 시장의 녹내장 치료제와 그 작용기서
  • 제네릭 의약품과 브랜드 의약품의 비교와 시장에 대한 영향
  • 녹내장 의약품 개발 파이프라인
  • 녹내장 치료제를 제조·판매하고 있는 기업 개요
ksm 24.06.05

What's New:

The "2024 Glaucoma Pharmaceuticals Market Report" features new regional sales forecasts that take into account appreciation of the dollar against other major currencies and an updated analysis of the prevalence and diagnosis of glaucoma that reflects COVID-19 mortality. The report now includes market share analysis of generics and branded drugs by drug class in the United States and Japan and prescription stratification by first-line and adjunctive use in the United States and Western European countries.

This new report also provides an updated analysis of the glaucoma pharma product pipeline, a summary of ongoing clinical trials, a review of Glaukos' recently approved iDose TR sustained drug delivery device, and survey data on US ophthalmologists' plans for sustained drug delivery.

The "2024 Glaucoma Pharmaceuticals Market Report" analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2029 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 26 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook.

This report provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. The global market is analyzed based on Market Scope's eight regional/economic categories (the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World), and also uses these categories in global forecasts for disease prevalence. In addition, the report explores data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Coverage includes:

  • Types of glaucoma and risk factors.
  • Diagnosis and treatment of the disease.
  • A global view of glaucoma care providers, including ophthalmologists and optometrists.
  • Current estimates and five-year forecasts for disease prevalence worldwide.
  • Glaucoma medications in the marketplace and their mechanisms of action.
  • Discussion of generic versus branded drugs and their market impact.
  • The development pipeline for glaucoma pharmaceuticals.
  • Profiles of companies making and marketing glaucoma medications.

Author Profile:

Peter Downs

Peter Downs Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제